Disappearance of diabetic macular hard exudates after hemodialysis introduction. [PDF]
, 2006 We report herein the disappearance of macular hard exudates after the introduction of hemodialysis in diabetic patients. A 62-year-old woman and a 52-year-old man with diabetes mellitus showed hard exudates in the macula of the left eyes.
Matsuo, Toshihiko
core +1 more source
Corneal graft failure due to migration of Ozurdex™ implant into the anterior chamber
American Journal of Ophthalmology Case Reports, 2017 Purpose: We report a case of corneal endothelial graft failure secondary to dexamethasone intravitreal implant (Ozurdex™) migration into the anterior chamber (AC).
Haifa A. Madi +2 more
doaj +1 more source
Effectiveness of the Dexamethasone Intravitreal Implant for Treatment of Patients with Diabetic Macular Oedema [PDF]
, 2014 Diabetic macular oedema (DMO) is a leading cause of vision loss in the working-age population worldwide. Corticosteroid drugs have been demonstrated to inhibit the expression of both the vascular endothelial growth factor (VEGF) gene and other anti ...
Alkabes, M, Dutra-Medeiros, M, Nucci, P
core +1 more source
Efficacy of 0.1% Topical Nepafenac in Maintaining Transoperative Mydriasis and Preventing Postoperative Macular Oedema in Phacoemulsification Cataract Surgery: A Research Protocol [PDF]
Journal of Clinical and Diagnostic ResearchIntroduction: Following standard cataract surgery, postoperative Cystoid Macular Oedema (CMO) may result in visual impairment. Currently, phacoemulsification is considered the best surgical technique for cataract extraction due to the superior visual ...
Srashti Jain, Pravin Tidake
doaj +1 more source
Alemtuzumab-induced remission of multiple sclerosis-associated uveitis [PDF]
, 2016 Purpose The purpose of the study was to report a case of multiple sclerosis (MS)-associated uveitis refractory to conventional immunosuppressants, with subsequent remission following treatment with alemtuzumab.
Carreño, Ester +5 more
core +4 more sources
Predictors of Long-Term Visual Outcome in Intermediate Uveitis [PDF]
, 2017 PURPOSE: To describe factors that predict visual loss and complications in intermediate uveitis. DESIGN: Cross-sectional study. PARTICIPANTS: Subjects with intermediate uveitis were identified from a database of 1254 uveitis patients seen ...
Bar, A +4 more
core +1 more source
The mystery of angiographically silent macular oedema due to taxanes [PDF]
, 2018 : Taxanes are widely used anticancer agents, produced from the plants of the genus Taxus (yews). One of the rare side-effects caused by taxanes is a bilateral cystoid macular oedema (CMO).
Cech, Petr +2 more
core
The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema [PDF]
, 2017 Aim: To assess the rate of ‘treatment-requiring diabetic macular oedema (DMO)’ in eyes for the two years before and after cataract surgery. Methods: Multicentre national diabetic retinopathy (DR) database study with anonymised data extraction across ...
Akerele, T. +25 more
core +1 more source
Cystoid macular oedema with trypan blue use [PDF]
British Journal of Ophthalmology, 2005 We read with interest the article by Gouws et al 1 on the apparent increased incidence of cystoid macular oedema (CMO) in phacoemulsification patients when trypan blue was used to stain the anterior capsule. Trypan blue has been commonly used in both anterior and posterior segment surgeries.2–4 If trypan blue does cause macular toxicity, its risks ...
openaire +1 more source
Nigerian Journal of MedicinePurpose: To evaluate the effectiveness of intravitreal faricimab for various retinal vascular diseases in a low-resource Nigerian setting and to provide preliminary insights that could inform future ophthalmological treatment protocols.
Tunji Sunday Oluleye +4 more
doaj +1 more source